Amy C. Peterson, EVP, Chief Development Officer: CytomX Therapeutics CTMX Sell · Filed 23/03/20

Trade details

Type: Insider sale
Amount: $8,428.86
Shares · price: 4,257 sh · $1.98 a share
Held after: 58,433 sh
Stock: CytomX Therapeutics CTMX
Person: Amy C. PetersonEVP, Chief Development Officer
Trade date: 23/03/16
Filed: 23/03/20
Days to filing: 4 days

Sold 6.8% of holdings

Share of holding sold: 6.8%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/14~23/04/15

Amy C. Peterson's recent trades

Amy C. PetersonEVP Prod Dev & Med Aff & CMO
SellExelixis
Sell
Exelixis
EXEL
$3.3M
72,776 sh
$3.3M
Filed 25/05/16
Traded 25/05/16
Amy C. PetersonEVP Prod Dev & Med Aff & CMO
Planned sale10b5-1 planExelixis
Planned sale10b5-1 plan
Exelixis
EXEL
$3.4M
72,776 sh
$3.4M
Filed 25/05/16
Traded 25/05/16

Amy C. Peterson, Chief Officer — sold $8,429 of CytomX Therapeutics CTMX · 6.8% of holdings | Whalegun